NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹7.04 Cr | ₹11 Cr | ₹3.23 Cr | ₹2.70 Cr | ₹2.55 Cr |
What is the latest Long Term Provisions ratio of NGL FINECHEM ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹7.04 Cr |
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹3.23 Cr |
| Mar2023 | ₹2.70 Cr |
| Mar2022 | ₹2.55 Cr |
How is Long Term Provisions of NGL FINECHEM Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹7.04 Cr | -37.18 | |
| Mar2025 | ₹11 Cr | 247.33 | |
| Mar2024 | ₹3.23 Cr | 19.30 | |
| Mar2023 | ₹2.70 Cr | 6.04 | |
| Mar2022 | ₹2.55 Cr | - | |
Compare Long Term Provisions of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,711.3 Cr | -3.9% | 1.9% | 82.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -3.9% |
1.9% |
82.3% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses